Top Stories
-
Compared to yearly screening, more frequent mammograms for women treated for early-stage breast cancer did not confer additional benefit, a study from Columbia University oncologists has found.
Topic
-
Seizures are usually considered a side effect of brain cancer, but a new Columbia University study of mice suggests they may also fuel the further growth of brain tumors.
Topic
-
Columbia University President Lee Bollinger announced the appointment of Anil Rustgi, MD, director of the Herbert Irving Comprehensive Cancer Center, as interim EVP and dean, effective July 1, 2020.
Topic
-
Scientists at Columbia's Herbert Irving Comprehensive Cancer Center are using technologies developed to study cancer to look for drugs to treat COVID-19 and disarm the virus.
Topic
Latest News
- December 20, 2017
Using electron microscopy, CUMC biologists have captured the first detailed images of a calcium membrane pore in action, revealing a potential target for treating cancer.
Topic
- December 14, 2017
An individual’s own genes play a role in the response to immunotherapy drugs, researchers in the Herbert Irving Comprehensive Cancer Center have found.
Topic
- December 8, 2017
A CUMC-led study finds that acupuncture can reduce the joint pain caused by aromatase inhibitors, a drug taken by two-thirds of all breast cancer patients.
Topic
- November 16, 2017
Columbia University and NYP announced today that Florence Irving and her late husband, Herbert Irving, have given $700 million to the two institutions to dramatically advance research and clinical programs for the treatment of cancer.
Topic
- November 16, 2017
Discoveries made by researchers at HICCC have fundamentally altered our understanding of cancer.
- October 11, 2017
Columbia researchers have identified cells that give rise to Barrett’s esophagus, a precursor to esophageal cancer, the fastest-growing cancer in the United States.
Topic
- October 9, 2017
Riders, sponsors, volunteers, and friends joined forces for Velocity, Columbia's Ride to End Cancer, in support of the Herbert Irving Comprehensive Cancer Center.
Topic
- September 7, 2017
Cancer immunotherapy drugs only work for a minority of patients, but a generic drug now used to increase blood flow may be able to improve those odds, a study by Columbia University Medical Center researchers suggests.
Topic
- August 30, 2017
Immunotherapy expert Pawel Muranski speaks about the new CAR-T therapy for leukemia and his work to bring T cell therapies to patients with a wide range of cancers.
Topic
- August 30, 2017
Prakash Satwani, MD, leads NYP/CUMC's program in CAR-T therapy, a new treatment that uses a patient's own T cells to attack cancer.
Topic
